NCT02205840View on ClinicalTrials.gov

A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

November 30, 2014

Conditions
Dry Eye Syndromes
Interventions
DRUG

SI-614

1 drop in each eye

DRUG

Vehicle

1 drop in each eye

Trial Locations (1)

Unknown

Andover

All Listed Sponsors
lead

Seikagaku Corporation

INDUSTRY

NCT02205840 - A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye. | Biotech Hunter | Biotech Hunter